Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Micha Abeles

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Arthritis Care & Research|October 17, 2022
Predictors of osteonecrosis in systemic lupus erythematosus: comment on the article by Kallas et alMicha Abeles, Jeffrey Urman
Cleveland Clinic Journal of Medicine|August 5, 2009
Pregabalin for fibromyalgiaMicha Abeles, Aryeh Abeles
The American Journal of Medicine|September 17, 2005
The Vioxx debacle revisitedMicha Abeles, Aryeh M Abeles
The American Journal of Medicine|February 12, 2013
The clinical utility of a positive antinuclear antibody test resultAryeh M Abeles, Micha Abeles
The American Journal of Medicine|September 24, 2013
The replyAryeh M Abeles, Micha Abeles
Arthritis Care & Research|July 8, 2017
Severity of disease, and not glucocorticoid use, determines outcomes in systemic lupus: comment on the article by Sheane et alAryeh M Abeles, Micha Abeles
Connecticut Medicine|April 5, 2007
A 58-year-old man with anti-Jo-1 syndrome and renal cell carcinoma: a case report and discussionGuada Respicio, Wassim Shwaiki, Micha Abeles
American Family Physician|June 11, 2008
Fibromyalgia remains a controversial medical enigmaMicha Abeles, Shira R Abeles, Aryeh M Abeles
Vascular|September 4, 2013
Thromboangiitis obliterans successfully treated with phosphodiesterase type 5 inhibitorsAryeh M Abeles, Mirela Nicolescu, Zachary Pinchover, et al.
Clinical Rheumatology|April 6, 2016
Antinuclear antibody testing: discordance between commercial laboratoriesAryeh M Abeles, Manuel Gomez-Ramirez, Micha Abeles, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Arthritis Care & Research|October 17, 2022
Predictors of osteonecrosis in systemic lupus erythematosus: comment on the article by Kallas et alMicha Abeles, Jeffrey Urman
Cleveland Clinic Journal of Medicine|August 5, 2009
Pregabalin for fibromyalgiaMicha Abeles, Aryeh Abeles
The American Journal of Medicine|September 17, 2005
The Vioxx debacle revisitedMicha Abeles, Aryeh M Abeles
The American Journal of Medicine|February 12, 2013
The clinical utility of a positive antinuclear antibody test resultAryeh M Abeles, Micha Abeles
The American Journal of Medicine|September 24, 2013
The replyAryeh M Abeles, Micha Abeles
Arthritis Care & Research|July 8, 2017
Severity of disease, and not glucocorticoid use, determines outcomes in systemic lupus: comment on the article by Sheane et alAryeh M Abeles, Micha Abeles
Connecticut Medicine|April 5, 2007
A 58-year-old man with anti-Jo-1 syndrome and renal cell carcinoma: a case report and discussionGuada Respicio, Wassim Shwaiki, Micha Abeles
American Family Physician|June 11, 2008
Fibromyalgia remains a controversial medical enigmaMicha Abeles, Shira R Abeles, Aryeh M Abeles
Vascular|September 4, 2013
Thromboangiitis obliterans successfully treated with phosphodiesterase type 5 inhibitorsAryeh M Abeles, Mirela Nicolescu, Zachary Pinchover, et al.
Clinical Rheumatology|April 6, 2016
Antinuclear antibody testing: discordance between commercial laboratoriesAryeh M Abeles, Manuel Gomez-Ramirez, Micha Abeles, et al.
Pageof 2